Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?
ConsumerLab SAMe review
Only one of eight tested products contained inaccurate amounts of the ingredient compared with label claims, online testing firm announces. In a 2000 study, ConsumerLab.com found six of 13 tested products contained less SAMe (S-adenosyl-methionine) than labeled (1"The Tan Sheet" April 10, 2000, In Brief). The improvement in results was consistent to data collected from a study earlier this month finding an improvement in the labeling accuracy of chondroitin supplements (2"The Tan Sheet" Nov. 3, 2003, In Brief)...
More from Archive
• By
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
• By
This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
• By
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
• By
A new pilot aims to take Brazil closer to ‘digital transformation.’
More from Pink Sheet
• By
The inclusion of investigational drugs in the Critical Medicines Act and new provisions on stockpiling are among the raft of amendments the European Parliament has made to the draft legislation.
• By
A meeting between the European Commission and industry stakeholders has revealed several areas of importance and lessons learned in relation to the EU Health Technology Assessment Regulation, which began to apply to certain medicinal products this year.
• By
The US FDA’s unprecedented publication of 89 recent CRLs for unapproved products comes with a promise to release future letters more promptly.